Example: Heart Attack

Clinical Trials on Glomerulonephritis, IGA

Total 125 results

    • NCT00521508
      Completed
      Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
      Conditions: Glomerulonephritis, IGA
    • NCT04342325
      Recruiting
      The Clinical Trial of ADR-001 for IgA Nephropathy
      Conditions: Glomerulonephritis , IGA
    • NCT00378443
      Unknown status
      ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
      Conditions: Glomerulonephritis, IGA
    • NCT02232776
      Completed
      Efficacy and Safety of Losartan in Children With Ig A Nephropathy
      Conditions: Glomerulonephritis, IGA
    • NCT04092491
      Recruiting
      Study of the IgA Repertoire During IgA Deposition Nephropathy.
      Conditions: Glomerulonephritis, IGA
    • NCT03633864
      Unknown status
      Fecal Microbiota Transplantation for Refractory IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT04438603
      Recruiting
      The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT01502579
      Completed
      An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
      Conditions: IgA Nephropathy
    • NCT03468972
      Not yet recruiting
      Effect of Immunosuppression in IgA Nephropathy
      Conditions: Biopsy-proven IgA Nephropathy
    • NCT03001947
      Recruiting
      IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
      Conditions: IgA Nephropathy
    • NCT04716231
      Not yet recruiting
      Atacicept in Subjects With IgA Nephropathy
      Conditions: IgA Nephropathy; Berger Disease
    • NCT04573478
      Recruiting
      Atrasentan in Patients With IgA Nephropathy
      Conditions: IgA Nephropathy; Immunoglobulin A Nephropathy
    • NCT02571842
      Unknown status
      Rituximab in Recurrent IgA Nephropathy
      Conditions: Recurrent IgA Nephropathy
    • NCT00793585
      Completed
      A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT01538433
      Completed
      A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT04042623
      Terminated
      Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT02808429
      Terminated
      Efficacy and Safety of Atacicept in IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT04557462
      Not yet recruiting
      A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT04578834
      Not yet recruiting
      Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
      Conditions: IgA Nephropathy
    • NCT02662283
      Unknown status
      Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
      Conditions: IGA Nephropathy
    • NCT02712697
      Unknown status
      Integrative Medicine of IgA Nephropathy
      Conditions: Primary IgA Nephropathy
    • NCT02471599
      Suspended
      Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT01758120
      Unknown status
      Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
      Conditions: IgA Nephropathy
    • NCT00657059
      Completed
      Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
      Conditions: IgA Nephropathy
    • NCT04684745
      Recruiting
      Open-Label Extension Study of BION-1301 in IgA Nephropathy
      Conditions: IgA Nephropathy
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations